English guide
Master the New TOEFL 2026 Integrated Writing task with vaccine development. Study 3-4 model answers (CEFR B2-C2), scoring breakdowns, and essential vocabulary.
What this guide covers
Search answer
Master the New TOEFL 2026 Integrated Writing task with vaccine development. Study 3-4 model answers (CEFR B2-C2), scoring breakdowns, and essential vocabulary.
Related guides:
A high-scoring New TOEFL 2026 Integrated Writing response on vaccine development must synthesize a reading passage and a lecture, highlighting contradictions in 150–225 words. Use precise reporting verbs and accurate scientific terminology. Below are four CEFR-aligned model responses, scoring rubrics, and 15+ vocabulary terms to help you target a 5.0–6.0 on the updated ETS exam.
Reading Passage: A university bulletin board announcement titled "Advancements in mRNA Vaccine Platforms" argues that modern mRNA vaccines are safer and more effective than traditional live-attenuated vaccines. It highlights three points: (1) mRNA does not interact with human DNA, eliminating mutation risks; (2) production timelines are 40% faster, enabling rapid pandemic response; and (3) cold-chain storage requirements have been eliminated through lipid nanoparticle stabilization, making global distribution feasible.
Lecture Audio: A biology professor challenges these claims. First, while mRNA itself doesn't alter DNA, the lipid nanoparticles used in delivery can trigger unpredictable immune responses in 12–15% of recipients, causing severe inflammation. Second, the 40% faster production claim ignores regulatory validation phases, which still take 18–24 months for safety trials. Third, the new lipid formulations remain unstable above 2°C, meaning ultra-cold storage is still mandatory for 65% of global shipments, contradicting the reading's feasibility argument.
Task Prompt: Summarize the lecture's points and explain how they challenge the reading passage. Write 150–225 words.
---
The lecture says that the reading is wrong about mRNA vaccines. First, the reading says mRNA is safe and doesn't change DNA. But the professor says the nanoparticles can cause bad immune reactions in some people, like 12 to 15 percent. This makes it unsafe. Second, the reading says vaccines are made 40% faster. The professor disagrees because safety tests still need 18 to 24 months, so it is not really faster. Third, the reading says we don't need cold storage anymore. The lecture says the new lipids still need cold storage, especially above 2 degrees. So 65% of shipments still need it. Overall, the professor thinks the reading is too optimistic about mRNA vaccines. The reading makes big claims about safety, speed, and distribution, but the lecture shows that there are still big problems with inflammation, testing time, and storage. That is why the lecture contradicts the reading on all three points.
The lecture directly challenges the reading passage regarding the safety, production speed, and distribution requirements of mRNA vaccines. First, the reading asserts that mRNA vaccines are completely safe because they do not interact with human DNA. However, the professor counters this by explaining that lipid nanoparticles used for delivery can trigger severe inflammatory responses in 12–15% of patients, posing a significant health risk. Second, the author claims that mRNA technology reduces production time by 40%. The lecturer disputes this, noting that regulatory safety trials still require 18–24 months, meaning the overall timeline remains lengthy. Finally, the reading argues that new lipid formulations have eliminated cold-chain storage needs. The professor refutes this, stating that these formulations remain unstable at temperatures above 2°C, requiring ultra-cold storage for 65% of global shipments. In conclusion, the lecture systematically undermines the reading's claims by highlighting unresolved safety concerns, prolonged validation periods, and persistent logistical challenges in vaccine distribution.
The professor systematically refutes the reading's optimistic assessment of mRNA vaccine platforms across three dimensions: immunological safety, regulatory timelines, and logistical feasibility. Whereas the passage claims that mRNA vaccines eliminate mutation risks by avoiding genomic integration, the lecturer emphasizes that the lipid nanoparticle delivery vectors frequently provoke adverse inflammatory cascades in 12–15% of recipients, undermining the safety narrative. Regarding production efficiency, the reading touts a 40% acceleration in manufacturing; however, the speaker clarifies that rigorous Phase III clinical validation still demands 18–24 months, effectively neutralizing any time-saving advantage. Finally, the text asserts that lipid stabilization has rendered cold-chain infrastructure obsolete. The professor contradicts this, demonstrating that current formulations degrade rapidly at temperatures exceeding 2°C, thereby preserving ultra-cold dependency for roughly two-thirds of international shipments. By exposing these critical discrepancies, the lecture dismantles the reading's premise that mRNA platforms represent an unequivocally superior and logistically streamlined alternative to conventional vaccine technologies.
The lecture systematically deconstructs the reading's assertions regarding mRNA vaccine safety, manufacturing efficiency, and global distribution. First, the passage argues that mRNA technology eliminates genomic mutation risks by operating independently of human DNA. The professor counters that lipid nanoparticle carriers, while non-integrative, routinely induce severe inflammatory responses in 12–15% of recipients, introducing a distinct immunological hazard. Second, the author highlights a 40% reduction in production timelines. The lecturer contextualizes this by noting that mandatory regulatory validation phases still require 18–24 months for comprehensive safety profiling, thereby nullifying the purported speed advantage. Third, the reading claims that advanced lipid formulations have obviated cold-chain dependencies. The speaker refutes this, citing thermal instability above 2°C that forces 65% of international shipments to maintain ultra-cold storage protocols. Consequently, the lecture demonstrates that the reading's conclusions regarding safety, efficiency, and logistical viability are fundamentally overstated, as unresolved biological, regulatory, and infrastructural constraints persist.
---
| Rubric Category | CEFR 4.0 Performance | CEFR 5.0 Performance | CEFR 6.0 Performance | |:---|:---|:---|:---| | Content & Synthesis | Identifies contradictions but oversimplifies scientific mechanisms. Missing precise lecture data. | Accurately captures all three lecture points with correct percentages and directly links to reading claims. | Demonstrates precise synthesis; uses exact lecture metrics and explicitly maps them to reading arguments. | | Organization & Cohesion | Basic structure (First, Second, Third). Repetitive transitions. | Clear paragraphing with logical progression. Uses contrast markers effectively. | Sophisticated academic structure. Seamless integration of lecture-reading relationships without listing. | | Lexical Resource | Basic vocabulary. Repeats "says," "bad," "faster." Limited collocations. | Academic register with appropriate scientific terms (e.g., lipid nanoparticles, cold-chain). | Precise, discipline-specific terminology (immunological hazard, genomic integration, thermal instability). | | Grammatical Range & Accuracy | Simple sentences dominate. Minor errors in subject-verb agreement and article usage. | Complex structures used accurately. Occasional punctuation slips. | Flawless syntax, varied clause structures, accurate use of subordinate and relative clauses. |
---
---
---
---
How is the 2026 TOEFL Integrated Writing scored? ETS now uses a 1–6 CEFR-aligned scale. Your raw score converts to a 0–30 scale for university reporting during the transition period. Responses are graded on content accuracy, synthesis quality, organization, and language precision.
Can I write more than 225 words? You can, but ETS graders penalize verbosity that dilutes synthesis. The optimal range is 190–210 words. Focus on precision, not length.
What is the difference between the old Independent task and the new Academic Discussion? The Independent task asked for personal opinions on general topics. The Academic Discussion (introduced July 2023, fully integrated into the 90-minute 2026 format) requires you to contribute to a simulated online academic forum, defending a position with examples and reasoning.
How much time do I have for the Integrated task in 2026? You receive 20 minutes total: 3 minutes to read the passage, followed by a 12-minute audio lecture, and 20 minutes to write. The entire Writing section takes 30 minutes for both tasks.
Do I need scientific knowledge to score well? No. All necessary information is contained in the reading and lecture. Your task is to accurately report and contrast the provided information, not to apply external expertise.
---
Get your own response scored by AI on English AIdol. Upload your draft, receive instant CEFR-aligned feedback, and track your progress toward test day.